The global digital genome market is anticipated to grow at a considerable CAGR of 8.7% during the forecast period. The key factors that are contributing to the market growth are increasing funding activities and grants by the government, research institutes, and companies operating in the market among others. Thus. owing to the increasing funding activated for digitalization is influencing the positive growth of the digital genome market. For instance,
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/digital-genome-market
- In July 2022, Ultima Genomics raised a $600 million investment community for a low-cost sequencing platform that delivers the $100 genome. The company is set to develop a new era in genomics by developing a “fundamentally new sequencing architecture which includes different approaches to flow cell engineering, sequencing chemistry, and machine learning.
- In September 2021, the Rockefeller Foundation in collaboration with 20 organizations from the public, private, and non-profit sectors funded $20 million by strengthening organizations’ abilities to sequence and share genomic information and other data rapidly. These newly funded grants have expanded country and regional capacity for sequencing the genomes of pathogens in sub-Saharan Africa, India, and the US.
- In September 2019, the National Institutes of Health (NIH) granted approximately $29.5 million for advancing the reference sequence to generate and maintain the most comprehensive reference sequence of the human genome. This was maintained by the National Human Genome Research Institute (NHGRI), which develops a multi-genome reference sequence that is as universal and complete and represents 350 genomes from the human population.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
o By Products
o By Application
o By End-User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Agilent technologies, inc., Bionano genomics inc., Illumina, inc., Intellia Therapeutics, Inc. PerkinElmer Inc., Thermo Fisher Scientific Inc., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Digital Genome Market Report Segment
By Products
- Sequencing & Analyzer Instruments
- DNA/RNA Analysis Kits
- Sequencing & Analysis Software
- Sample Preparation Instruments
By Application
- Microbiology
- Reproductive & Genetic
- Transplantation and Agriculture
- Forensics
- Research and Development
By End-User
- Hospitals
- Academic Research Institutes
- Diagnostics & Forensic Labs
- Bio-pharmaceutical Companies
A full report of Digital Genome Market is available at: https://www.omrglobal.com/industry-reports/digital-genome-market
Digital Genome Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- 10x Genomics, Inc.
- 23andMe, Inc
- Azenta US, Inc.
- BGI Group
- bioMérieux SA
- Bionano Genomics, Inc.
- CRISPR Therapeutics
- Futura Genetics
- Genome Me Inc.
- Inscripta, Inc.
- Intellia Therapeutics, Inc.
- Invitae Corp
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
